維生素 K Vitamin K
A 1 B 1 C 2 D 2 U 1
適應症與證據等級
新生兒出血預防 Hemorrhage Prevention Newborn
A 🔵 A 中度證據 已發布 ✨ 低市場風險
→
骨質疏鬆症 Osteoporosis
B 🟡 B 初步證據 附警語發布 🚨 高市場風險
→
血管鈣化 Vascular Calcification
C 🟠 C 薄弱證據 附警語發布 🚨 高市場風險
→
關節炎(骨關節炎 / 類風濕性關節炎) Arthritis
C 🟠 C 薄弱證據 已發布 🚨 高市場風險
→
心血管疾病 Cardiovascular Disease
D 🔴 D 反證據 證據不足 🚨 高市場風險
→
骨折 Bone Fracture
D 🔴 D 反證據 主流反證據 ⚠️ 中度市場風險
→
代謝功能異常相關脂肪肝病 Masld
U ⚫ U 未驗證 證據不足 🚨 高市場風險
→
法規與權威立場 (L4)
L4a · US FDA
立場:supportive
Vitamin K1 Injection is indicated for prophylaxis and treatment of vitamin K-deficiency bleeding in neonates
來源 ↗ L4b · EU EFSA
立場:supportive
a cause and effect relationship has been established between the dietary intake of vitamin K and normal blood coagulation ... and the maintenance of normal bone
來源 ↗ L4c · UK NHS
立場:cautious
You should be able to get all the vitamin K you need by eating a varied and balanced diet. Any vitamin K your body does not need immediately is stored in the liver for future use, so you do not need it in your diet every day.
來源 ↗ L4e · WHO
立場:supportive
vitamin K1 should be given to all newborns as a single, intramuscular dose of 0.5–1 mg
來源 ↗ 市場與行銷 (L10)
L10a · TW Market Channels
納豆萃取天然維生素K2
L10b · TW Legal Identity (TFDA)
預防或治療新生兒維生素K缺乏性出血
L10c · TW Community (PTT/Dcard/Mobile01)